Highlights • HSV hepatitis is a rare and fatal entity that can be a donor-derived infection. • It should be suspected in highly immunosuppressed transplant patients who develop acute liver failure. • The treatment delay is associated with higher fatality. • In transplant patients with negative HSV serology, prophylaxis is recommended if they are not with prophylaxis for CMV.
All Keywords
【저자키워드】 HSV-1, transplantation, SOT, Donor derived transmitted disease, Herpes simplex virus hepatitis,
【저자키워드】 HSV-1, transplantation, SOT, Donor derived transmitted disease, Herpes simplex virus hepatitis,